Abstract
Living longer with sustainable quality of life is becoming increasingly important in aging populations. Understanding associative biological mechanisms have proven daunting, because of multigenicity and population heterogeneity. Although Big Data and Artificial Intelligence (AI) could help, naïve adoption is ill advised. We hold the view that model organisms are better suited for big-data analytics but might lack relevance because they do not immediately reflect the human condition. Resolving this hurdle and bridging the human–model organism gap will require some finesse. This includes improving signal:noise ratios by appropriate contextualization of high-throughput data, establishing consistency across multiple high-throughput platforms, and adopting supporting technologies that provide useful in silico and in vivo validation strategies. Understanding the complex phenotypes of aging and longevity requires careful examination and appropriate contextualization of multi-omic big data, strategic use of new technology, and a continued focus on animal models.
Original language | English |
---|---|
Pages (from-to) | 2273-2285 |
Number of pages | 13 |
Journal | Drug Discovery Today |
Volume | 24 |
Issue number | 12 |
DOIs | |
Publication status | Published - Dec 2019 |
Externally published | Yes |
Bibliographical note
Publisher Copyright:© 2019 Elsevier Ltd
ASJC Scopus Subject Areas
- Pharmacology
- Drug Discovery